ABPO

Abpro Holdings, Inc.

OTC· Biological Products, (No Diagnostic Substances)· Inc. DE· CIK 0001893219 Biotech & Drug Discovery

$0.4210 +0.02 (+4.99%)

Oct 23 4:00 PM ET · prev $0.4010

1 year

−93.0%

from $6.00 · Oct 24

30 days

+6.3%

from $0.3960

52-week range

$0.1000–7.04

−94% from high · low Mar 9

Avg volume 20D

5.5K

Oct 21 spike 20.0K

Short interest

16.1K

+31.6%

Days to cover

1.0

at average volume

Filing reports

analyzed by SecBot

SecBot read BEARISH 1 report · 90 days

Balance 1 bearish · 0 bullish oldest → newest, height = score

Avg score

·High conf. 1/1

Strongest BEARISH Nasdaq has filed Form 25-NSE to remove Abpro Holdings, Inc. from listing, effective October 12, 2026, after…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

X Jul 15 Short interest falls 30.0% to 16.3K
X Aug 14 Short interest jumps 26.8% to 16.5K
R Sep 30 Nasdaq has filed Form 25-NSE to remove Abpro Holdings, Inc. from lis…
X Sep 30 Short interest jumps 31.6% to 16.1K

Signal stack

Where each data set points today.

Short sellersBUILDING

Short interest +31.6% to 16.1K shares. 1.0 days to cover.
TrendUPTREND

32% above its 50-day average.

Who's buying

13F

Top holder	Shares	Value
VANGUARD GROUP INC	20,084	$85.0K
GOLDMAN SACHS GROUP INC	12,383	$52.4K
GEODE CAPITAL MANAGEMENT, LLC	10,785	$45.6K
LMR Partners LLP	2,084	$8.8K
Clear Street Group Inc.	436	$1.8K
UBS Group AG	315	$1.3K
BANK OF AMERICA CORP /DE/	15	$64.00

Quarterly 13F filings are due 45 days after each quarter ends.

Recent activity

The latest filings, insider trades, analyst actions, press and options flow — newest first.

Sep 30, 2026 SEC

Nasdaq has filed Form 25-NSE to remove Abpro Holdings, Inc. from listing, effective October 12, 2026, after a…

25-NSE — Impact 9/10

Earnings setup

Estimates

Revision history: 🔒 Fresh data — subscribers only

Period	EPS est.	Range	30D rev.	Revenue
Current Q	🔒 Fresh data — subscribers only
Next Q	🔒 Fresh data — subscribers only
Current FY	🔒 Fresh data — subscribers only
Next FY	🔒 Fresh data — subscribers only

Short side

FINRA· Sep 30, 2026

16,099

shares short

+31.6%

vs prior settlement

1.0

days to cover

SecBot reports

1 filings · 0 bullish · 1 bearish

BEARISH 25-NSE

Sep 30, 2026

Nasdaq has filed Form 25-NSE to remove Abpro Holdings, Inc. from listing, effective October 12…

With all Nasdaq appeals exhausted and the delisting date set, the stock will likely trade on OTC markets with significantly reduced liquidity. Monitor for any potential OTCQB or OTCQX listing, or a…

Confidence high · Horizon immediate

All ABPO filing & press-release reports (1)

25-NSE reportSep 30, 2026